{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T02:39:28Z","timestamp":1788575968767,"version":"build-2803163510"},"reference-count":45,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2016,5,16]],"date-time":"2016-05-16T00:00:00Z","timestamp":1463356800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0155644","type":"journal-article","created":{"date-parts":[[2016,5,16]],"date-time":"2016-05-16T17:47:24Z","timestamp":1463420844000},"page":"e0155644","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":28,"title":["Predictive Value of C-Reactive Protein (CRP) in Identifying Fatal Outcome and Deep Infections in Staphylococcus aureus Bacteremia"],"prefix":"10.1371","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1899-1223","authenticated-orcid":true,"given":"Tomi","family":"M\u00f6lk\u00e4nen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eeva","family":"Ruotsalainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esa M.","family":"Rintala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asko","family":"J\u00e4rvinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,5,16]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1097\/01.CCM.0000239121.09533.09","article-title":"Healthcare-associated bloodstream infection: A distinct entity? Insights from a large U.S. database","volume":"34","author":"AF Shorr","year":"2006","journal-title":"Crit Care Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/jac\/dkq424","article-title":"Mortality associated with in-hospital bacteraemia caused by Staphylococcus aureus: a multistate analysis with follow-up beyond hospital discharge","volume":"66","author":"M Wolkewitz","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1086\/317421","article-title":"Staphylococcus aureus bacteremia: predictors of 30-day mortality in a large cohort","volume":"31","author":"JM Mylotte","year":"2000","journal-title":"Clin Infect Dis"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1001\/archinte.163.17.2066","article-title":"Clinical identifiers of complicated Staphylococcus aureus bacteremia","volume":"163","author":"VG Fowler Jr","year":"2003","journal-title":"Arch Intern Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s10096-003-1083-3","article-title":"Long-term outcome and quality of care of patients with Staphylococcus aureus bacteremia","volume":"23","author":"G Fatkenheuer","year":"2004","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1469-0691.2006.01589.x","article-title":"Increasing incidence but decreasing in-hospital mortality of adult Staphylococcus aureus bacteraemia between 1981 and 2000","volume":"13","author":"T Benfield","year":"2007","journal-title":"Clin Microbiol Infect"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s10096-008-0515-5","article-title":"Outcome for invasive Staphylococcus aureus infections","volume":"27","author":"G Jacobsson","year":"2008","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref8","article-title":"Predisposing factors, disease progression and outcome in 430 prospectively followed patients of healthcare- and community-associated Staphylococcus aureus bacteraemia","author":"E Forsblom","year":"2011","journal-title":"J Hosp Infect"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jinf.2009.07.015","article-title":"Mortality of S. aureus bacteremia and infectious diseases specialist consultation\u2014a study of 521 patients in Germany","volume":"59","author":"S Rieg","year":"2009","journal-title":"J Infect"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"R15","DOI":"10.1186\/cc8872","article-title":"Sepsis biomarkers: a review","volume":"14","author":"C Pierrakos","year":"2010","journal-title":"Crit Care"},{"key":"ref11","article-title":"Elevated soluble urokinase plasminogen activator receptor (suPAR) predicts mortality in Staphylococcus aureus bacteremia","author":"T Molkanen","year":"2011","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jinf.2011.12.006","article-title":"Apoptosis markers soluble Fas (sFas), Fas Ligand (FasL) and sFas\/FasL ratio in patients with bacteremia: a prospective cohort study","volume":"64","author":"R Huttunen","year":"2012","journal-title":"J Infect"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"e87741","DOI":"10.1371\/journal.pone.0087741","article-title":"High cell-free DNA predicts fatal outcome among Staphylococcus aureus bacteraemia patients with intensive care unit treatment","volume":"9","author":"E Forsblom","year":"2014","journal-title":"PLoS One"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1007\/s10096-008-0541-3","article-title":"Serum procalcitonin has the potential to identify Staphylococcus aureus endocarditis","volume":"27","author":"F Cuculi","year":"2008","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.amjmed.2010.07.018","article-title":"Procalcitonin in 759 patients clinically suspected of infective endocarditis","volume":"123","author":"JB Knudsen","year":"2010","journal-title":"Am J Med"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"48487","DOI":"10.1074\/jbc.R400025200","article-title":"C-reactive Protein","volume":"279","author":"S Black","year":"2004","journal-title":"J Biol Chem"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"R63","DOI":"10.1186\/cc4892","article-title":"Early identification of intensive care unit-acquired infections with daily monitoring of C-reactive protein: a prospective observational study","volume":"10","author":"P Povoa","year":"2006","journal-title":"Crit Care"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1378\/chest.123.6.2043","article-title":"C-reactive protein levels correlate with mortality and organ failure in critically ill patients","volume":"123","author":"SM Lobo","year":"2003","journal-title":"Chest"},{"key":"ref19","article-title":"Genetic polymorphism of the C-reactive protein (CRP) gene and a deep infection focus determine maximal serum CRP level in Staphylococcus aureus bacteremia","author":"T Molkanen","year":"2010","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1365-2796.2005.01598.x","article-title":"Levofloxacin does not decrease mortality in Staphylococcus aureus bacteraemia when added to the standard treatment: a prospective and randomized clinical trial of 381 patients","volume":"259","author":"E Ruotsalainen","year":"2006","journal-title":"J Intern Med"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/1471-2334-6-137","article-title":"Clinical manifestations and outcome in Staphylococcus aureus endocarditis among injection drug users and nonaddicts: a prospective study of 74 patients","volume":"6","author":"E Ruotsalainen","year":"2006","journal-title":"BMC Infect Dis"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1001\/archinte.1962.03620240029006","article-title":"Gram-negative bacteremia. I. Etiology and ecology","volume":"110","author":"WR McCabe","year":"1962","journal-title":"Arch Intern Med"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1086\/313753","article-title":"Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis","volume":"30","author":"JS Li","year":"2000","journal-title":"Clin Infect Dis"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1097\/01.CCM.0000050454.01978.3B","article-title":"2001 SCCM\/ESICM\/ACCP\/ATS\/SIS International Sepsis Definitions Conference","volume":"31","author":"MM Levy","year":"2003","journal-title":"Crit Care Med"},{"issue":"6","key":"ref25","first-page":"716","article-title":"A New Look at the Statistical Model Identification","volume":"19","author":"H Akaike","year":"1974","journal-title":"A New Look at the Statistical Model Identification"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"e007049","DOI":"10.1136\/bmjopen-2014-007049","article-title":"Prognostic utility of serum CRP levels in combination with CURB-65 in patients with clinically suspected sepsis: a decision curve analysis","volume":"5","author":"S Yamamoto","year":"2015","journal-title":"BMJ Open"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1097\/00003246-199909000-00018","article-title":"Sensitivity and specificity of various markers of inflammation for the prediction of tumor necrosis factor-alpha and interleukin-6 in patients with sepsis","volume":"27","author":"M Oberhoffer","year":"1999","journal-title":"Crit Care Med"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.amjmed.2007.10.033","article-title":"C-reactive protein is an independent predictor of severity in community-acquired pneumonia","volume":"121","author":"JD Chalmers","year":"2008","journal-title":"Am J Med"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"R169","DOI":"10.1186\/cc10313","article-title":"C-reactive protein, an early marker of community-acquired sepsis resolution: a multi-center prospective observational study","volume":"15","author":"P Povoa","year":"2011","journal-title":"Crit Care"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"e17653","DOI":"10.1371\/journal.pone.0017653","article-title":"High plasma level of long pentraxin 3 (PTX3) is associated with fatal disease in bacteremic patients: a prospective cohort study","volume":"6","author":"R Huttunen","year":"2011","journal-title":"PLoS One"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1007\/s00134-002-1416-1","article-title":"Predictive value of procalcitonin and interleukin 6 in critically ill patients with suspected sepsis","volume":"28","author":"V Pettila","year":"2002","journal-title":"Intensive Care Med"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s00134-009-1402-y","article-title":"Is C-reactive protein a good prognostic marker in septic patients?","volume":"35","author":"J Silvestre","year":"2009","journal-title":"Intensive Care Med"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/MD.0b013e3181b8fccb","article-title":"Infectious diseases consultation lowers mortality from Staphylococcus aureus bacteremia","volume":"88","author":"T Lahey","year":"2009","journal-title":"Medicine (Baltimore)"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"e6512","DOI":"10.1371\/journal.pone.0006512","article-title":"Factors predicting and reducing mortality in patients with invasive Staphylococcus aureus disease in a developing country","volume":"4","author":"EK Nickerson","year":"2009","journal-title":"PLoS One"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.amjmed.2010.01.015","article-title":"The value of infectious diseases consultation in Staphylococcus aureus bacteremia","volume":"123","author":"H Honda","year":"2010","journal-title":"Am J Med"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"32","DOI":"10.2307\/30141354","article-title":"Risk factors for mortality in Staphylococcus aureus bacteremia","volume":"19","author":"LO Conterno","year":"1998","journal-title":"Infect Control Hosp Epidemiol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1086\/313650","article-title":"Pathogenic significance of methicillin resistance for patients with Staphylococcus aureus bacteremia","volume":"30","author":"A Soriano","year":"2000","journal-title":"Clin Infect Dis"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1080\/00365540310016682","article-title":"Staphylococcus aureus bacteremia: compliance with standard treatment, long-term outcome and predictors of relapse","volume":"35","author":"LB Johnson","year":"2003","journal-title":"Scand J Infect Dis"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1001\/archinte.162.1.25","article-title":"Treatment and outcome of Staphylococcus aureus bacteremia: a prospective study of 278 cases","volume":"162","author":"AG Jensen","year":"2002","journal-title":"Arch Intern Med"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/01.md.0000091184.93122.09","article-title":"Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study","volume":"82","author":"FY Chang","year":"2003","journal-title":"Medicine (Baltimore)"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/cid\/cis889","article-title":"Telephone consultation cannot replace bedside infectious disease consultation in the management of Staphylococcus aureus Bacteremia","volume":"56","author":"E Forsblom","year":"2013","journal-title":"Clin Infect Dis"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1111\/j.1469-0691.2010.03156.x","article-title":"Close cooperation between infectious disease physicians and attending physicians can result in better management and outcome for patients with Staphylococcus aureus bacteraemia","volume":"16","author":"M Nagao","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1001\/archinte.158.5.509","article-title":"Bacteremic Staphylococcus aureus spondylitis","volume":"158","author":"AG Jensen","year":"1998","journal-title":"Arch Intern Med"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/0090-3019(90)90047-S","article-title":"Diagnosis and management of pyogenic vertebral osteomyelitis in adults","volume":"33","author":"RK Osenbach","year":"1990","journal-title":"Surg Neurol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/1741-7015-9-107","article-title":"Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future","volume":"9","author":"P Schuetz","year":"2011","journal-title":"BMC Med"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0155644","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T10:25:31Z","timestamp":1589019931000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0155644"}},"subtitle":[],"editor":[{"given":"Pedro","family":"P\u00f3voa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,5,16]]},"references-count":45,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2016,5,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0155644","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,16]]}}}